Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
nanoparticles contribute to diseases. Environmental Nanoparticles of interest include those emitted from wildfires, traffic and micro-nanoplastics, the byproduct of degradation of plastics in environmental media
-
postdoctoral researcher position to work on a project to functionalize lipid nanoparticles for the targeted inhibition of signaling pathways in specific cell lines. The project includes: Design and validation
-
Offer Description R2-A RESEARCHER. - REQUIRED DEGREE: PhD in Biomedicine/Microbiology. - PROJECT: "Formulation of Bacteriophages as Liposomes and Nanoparticles with potential application to the treatment
-
undertake a PhD in the NanoPhotonics Group (NP) led by Prof Jeremy J Baumberg, FRS (https://www.np.phy.cam.ac.uk/ ), as part of a prestigious European collaboration on building DNA origami for nanomachinery
-
, nuclear structure, neutrino physics, and fundamental interactions. The nuclear astrophysics part of the research is related to the newly established Centre of Excellence in Neutron-Star Physics (https
-
Centre of Excellence in Neutron-Star Physics (https://neutronstars.fi ), funded by the Research Council of Finland. The CoE status provides us long-term funding, strong connections to related Finnish and
-
of Excellence in Neutron-Star Physics (https://neutronstars.fi ), funded by the Research Council of Finland. The CoE status provides us long-term funding, strong connections to related Finnish and international
-
and animal models. Develop and optimize siRNA formulations and encapsulation strategies in lipid- or nanoparticle-based delivery systems. Perform in vivo testing of siRNA-loaded nanoliposomes in disease
-
chemical composition of biological nanoparticles, notably extracellular vesicles (EVs) and microbacteria. Current methods to characterize these particles are too slow and bulky. We want to make an on-chip
-
organoid platforms (hIPSC), lipid nanoparticle (LNP)-mRNA with scaling and QC, and antisense oligonucleotide to perturb human m(i)RNA targets. Benchmarking platforms in rodent models and human organoids